Dr. Lisa Nash, a TCOM graduate, will continue to lead the college toward excellence. Leadership at The University of North ...

Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA), a clinical stage biopharmaceutical company that has been developing a treatment ...

Shares Expected to Begin Trading on Split-Adjusted Basis on March 18, 2025 MORRISTOWN, N.J., March 14, 2025 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA), a clinical stage biopharmac ...

NAFLD, the most prevalent liver disease, affects approximately 25% of the global population (1.2 billion people), including 188 million in India. Left untreated, NAFLD can progress to non-alcoholic ...

A group of around half a dozen pharma companies are trying to develop treatment for NASH, for which there is no approved treatment. The market for NASH drugs is expected to exceed $1 billion soon ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Fintel reports that on March 14, 2025, Goldman Sachs initiated coverage of 89bio (NasdaqGM:ETNB) with a Neutral ...

A group of state lawmakers and a Macomb County official want stricter limits than the state proposes for Oakland County's ...

There is currently no approved treatment for NASH, but its prevalence is likely to increase in coming years as obesity rates rise – and this has led analysts to predict that new drugs in this ...

Dry spells are common in many relationships, but if this is becoming a problem, you can get your groove back. Here are some tips to help keep that flame alive.

Equities research analysts at HC Wainwright reduced their Q1 2025 earnings per share estimates for shares of Aligos Therapeutics in a report issued on Tuesday, March 11th. HC Wainwright analyst E.